weight loss drugs not semaglutide drugs: 2024 expectations for Wegovy, Ozempic, Zepbound In the Weight-Loss Wars, Novo's

Woolley and the other, anonymous reviewer(s) for their contribution to the peer review of this work

In trials, oral semaglutide produced roughly 13.6 to 16.6 percent weight loss at 64 weeks

International Journal of Cosmetic Science, 2005

Discover more award-winning shows at podcasts.voxmedia.com

Your care team can help you adjust your treatment plan, explore alternative compounds like tirzepatide, or investigate whether genetic factors (revealed by the Precision Peptide Genetic Test) suggest a different peptide protocol might work better for your physiology

These interventions require minimal additional provider time while ensuring systematic assessment (Grundstrm et al., 2018)